Tillomed

Tillomed is a European Pharmaceutical company with headquarters in the UK and subsidiaries in Spain, Germany, and Italy. Tillomed specialises in the licensing and marketing of cost-effective generic pharmaceuticals and is focused on growth through product launches and EU expansion. Our ambition is to grow our commercial structure in Europe and to accelerate our expansion through sustainable partnerships. We strive to offer new medicines that meet genuine needs and deliver effective, high-quality, sustainable healthcare. Tillomed is owned by Emcure, a privately held company with a strong track record of launching high quality, innovative medicines. Emcure is one of India's leading pharmaceutical companies with employees in over 70 countries and sales over $800m.